Ovarian Cancer Survival: Steady Improvement, Despite Rhetoric to the Contrary Maurie Markman Invited Commentary 10 August 2013 Pages: 433 - 435
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How John MagenauDaniel R. Couriel Leukemia (A Aguayo, Section Editor) 21 August 2013 Pages: 436 - 444
Acute Promyelocytic Leukemia: Do We Have a New Front-Line Standard of Treatment? Miguel A. SanzGloria IacoboniPau Montesinos Leukemia (A Aguayo, Section Editor) 29 August 2013 Pages: 445 - 449
Genetic Factors and Pathogenesis of Waldenström’s Macroglobulinemia Jorge MongeEsteban BraggioStephen M. Ansell Lymphomas (PA Hamlin, Section Editor) 31 July 2013 Pages: 450 - 456
Therapeutic Options for Adult T-Cell Leukemia/Lymphoma Ambroise MarçaisFelipe SuarezAli Bazarbachi Lymphomas (PA Hamlin, Section Editor) 14 August 2013 Pages: 457 - 464
Current Treatment of Locoregional Recurrence of Melanoma Malcolm Hart Squires IIIKeith A. Delman Melanoma (KB Kim, Section Editor) 02 August 2013 Pages: 465 - 472
MEK Inhibition in the Treatment of Advanced Melanoma April K. S. SalamaKevin B. Kim Melanoma (KB Kim, Section Editor) 23 August 2013 Pages: 473 - 482
Melanoma Brain Metastases: an Unmet Challenge in the Era of Active Therapy Vikram GorantlaJohn M. KirkwoodHussein A. Tawbi Melanoma (KB Kim, Section Editor) 17 August 2013 Pages: 483 - 491
Inhibition of Angiogenesis for the Treatment of Metastatic Melanoma Aaron S. MansfieldSvetomir N. Markovic Melanoma (KB Kim, Section Editor) 05 September 2013 Pages: 492 - 499
Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions David B. PageMichael A. PostowJedd D. Wolchok Melanoma (KB Kim, Section Editor) 10 August 2013 Pages: 500 - 508